Exogenous BH4 supplementation could rescue the cardiac and mitochondrial defects of Spr–/– mouse and decrease diurnal tyrosine variations in patients with phenylketonuria caused by Pah deficiency (Kim et al., 2019; van Wegberg et al., 2021). Here, PAH is linked to phenylketonuria.